ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

The FDA's compounding advisory committee will review seven peptides on July 23-24 for possible approval. Needham research sizes the addressable peptide market at roughly $30 billion. Telehealth companies like Hims & Hers are poised to enter the space, with its chief medical officer testifying at the hearing.
Tap to vote and see what everyone thinks.
Summary by ByteBrief